September 9, 2016 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Higher in the next 6 months. Seattle Genetics, Inc. (NASDAQ:SGEN), iPass Inc. (NASDAQ:IPAS) are all expected to go Higher as Buy signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Higher along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

  Symbol  Company Name                     Insider Name                     Role     Shares      Insider Score  Avg 6 Month Return  # of Dec. 
  SGEN    Seattle Genetics, Inc.           Baker, Felix J. Ph.D.            DO       414,016     95             12.4%               20        
  IPAS    iPass Inc.                       Griffiths, Gary Alan             CEO      5,000       91             22.1%               8

The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.

Seattle Genetics, Inc. (NASDAQ:SGEN) - Seattle Genetics, Inc., a biotechnology company, develops and commercializes targeted therapies for the treatment of cancer worldwide. It markets ADCETRIS (brentuximab vedotin), an antibody-drug conjugate for the treatment of relapsed Hodgkin lymphoma and relapsed systemic anaplastic large cell lymphoma. The company also develops SGN-CD33A, which is in Phase 1b trial for patients with newly diagnosed acute myeloid leukemia (AML); Phase 1/2 trial for patients with relapsed or refractory AML; Phase 1/2 trial for patients with previously untreated myelodysplastic syndrome; and Phase 1 trial for patients with AML. In addition, it is developing SGN-CD19A that is in Phase 2 trials for patients with relapsed or refractory diffuse large B-cell lymphoma, as well as in Phase 1 trial for relapsed or refractory B-cell non-Hodgkin lymphomas, and relapsed or refractory B-cell acute lymphoblastic leukemia; SGN-LIV1A, which is in Phase 1 trial for the treatment of LIV-1-positive metastatic breast cancer; SGN-CD70A that is in Phase 1 trial for the treatment of CD70-positive renal cell carcinoma; SEA-CD40, which is in Phase 1 trial for the treatment of CD40-positive solid tumors; ASG-22ME that is in Phase 1 trial for the treatment of Nectin-4-positive solid tumors, including bladder cancer; and ASG-15ME, which is in Phase 1 trial for the treatment of bladder cancer. The company has collaborations for its ADC technology with various biotechnology and pharmaceutical companies, including AbbVie Biotechnology Ltd.; Bayer Pharma AG; Celldex Therapeutics, Inc.; Genentech, Inc.; GlaxoSmithKline LLC; Pfizer, Inc.; PSMA Development Company LLC; Takeda Pharmaceutical Company Limited; and Unum Therapeutics, Inc. Seattle Genetics, Inc. was founded in 1998 and is headquartered in Bothell, Washington..

iPass Inc. (NASDAQ:IPAS) - iPass Inc. provides Wi-Fi network that enables Wi-Fi access on various mobile devices in the United States and internationally. The company offers mobile connectivity services that provide cloud-based solution allowing customers and their users access to its Wi-Fi network to stay connected to the people and information. It offers business to business mobile connectivity solutions to large and small enterprises, as well as to strategic partnerships comprising original equipment manufacturers, loyalty programs, software product and service providers, and communication companies; and iPass SmartConnect that takes the guesswork out of Wi-Fi automatically connecting customers to the hotspot for their needs. The company operates hotspots in approximately 100 countries, at airports, hotels, train stations, convention centers, outdoor venues, inflight, and others. iPass Inc. sells its services directly through its global sales force, as well as through reseller and strategic partners. iPass Inc. was founded in 1996 and is headquartered in Redwood Shores, California..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

N※N

SGEN, IPAS, Expected to Trade Higher After Bullish Insider Trading